Evidence map›Paper›PMID 18312675›Full record

ArticleBMC cancer2008

Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.

Cindy Simoens, Filip Lardon, Bea Pauwels, Christel M J De Pooter, Hilde A J Lambrechts, Greet G O Pattyn, Fabienne Breillout, Jan B Vermorken

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Overview of preoperative radiochemotherapy in breast cancer: past or future?Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2011
    Review
  7. Vinflunine.Drugs · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Cindy SimoensLaboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp (UA/UZA), Wilrijk (Antwerp), Belgium. cindy.simoens@ua.ac.be
Filip Lardon
Bea Pauwels
Christel M J De Pooter
Hilde A J Lambrechts
Greet G O Pattyn
Fabienne Breillout
Jan B Vermorken
University of Antwerp · BEGZA Ziekenhuizen Campus Sint-Augustinus · BEPierre Fabre (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVinca alkaloids are an important class of anticancer agents and semisynthetic vinca alkaloids are developed to improve the therapeutic index of this class of drugs. In the present study, a direct comparison was made between vinflunine and vinorelbine regarding their radiosensitizing and cell cycle effects.

methodsFour human tumour cell lines were tested under identical experimental conditions, using equitoxic concentrations of vinflunine and vinorelbine.

resultsVinflunine and vinorelbine induced a comparable radiosensitizing effect (p-value never below 0.01) when cells were incubated for 24 h immediately prior to radiation. Regarding the cell cycle effects, a statistically significant concentration-dependent G2/M block was seen after 24 h incubation with vinorelbine in all tested cell lines. Similar results, with small cell line-related differences, were observed with vinflunine.

conclusionThe radiosensitizing effects of both semisynthetic vinca alkaloids were comparable (not statistically different) and nearly always cell line-specific and concentration-dependent. The cell cycle effects could be related to the observed radiosensitizing effects. Considering the more favourable toxicity profile of vinflunine, this agent might be more promising than vinorelbine for chemoradiation studies in the clinic.

Indexed as

Antineoplastic Agents, PhytogenicBreast NeoplasmsCarcinomaCarcinoma, Non-Small-Cell LungCell CycleCell Line, TumorDose-Response Relationship, DrugFemaleGamma RaysHumansLung NeoplasmsMicrotubulesMolecular StructureRadiation-Sensitizing AgentsStructure-Activity RelationshipTongue NeoplasmsAntineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsVinblastinevinflunineVinorelbine

Identifiers

PMID18312675
PMCPMC2311317
OpenAlexW2038215064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.